FT News Briefing Rise of the Russian informer
Apr 11, 2023
Amid a climate of fear in wartime Russia, citizens are increasingly reporting on one another, driven by government rhetoric. This unsettling environment is contrasted with corporate struggles in the U.S., including an anticipated drop in S&P 500 earnings. Additionally, concerns arise around proposed changes in Europe that could affect pharmaceutical investment and access to new drugs, as companies warn of potential impacts on treatment for chronic conditions. Tupperware's financial woes highlight ongoing challenges in the market.
AI Snips
Chapters
Transcript
Episode notes
Corporate Profit Plunge
- Corporate America faces its sharpest profit drop since the COVID-19 pandemic's start.
- High inflation and recession fears squeeze margins and hold back demand.
Pharmaceutical Innovation at Risk
- Eli Lilly's CEO warns that reduced market exclusivity in the EU could discourage drug development.
- He suggests this could impact research on chronic diseases and cancer.
Moscow Metro Incident
- A man on the Moscow metro was reported to police for viewing war-related content on his phone.
- He received a 14-day jail sentence, highlighting the increased surveillance and paranoia.